OLEMA PHARMACEUTICALS INC (OLMA)
US68062P1066 - Common Stock
ChartMill assigns a Buy % Consensus number of 85% to OLMA. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 25.25. This target is 132.35% above the current price.
OLMA was analyzed by 16 analysts. The buy percentage consensus is at 85. So analysts seem to be very confident about OLMA.
In the previous month the buy percentage consensus was at a similar level.
OLMA was analyzed by 16 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-04-02 | Goldman Sachs | Initiate | Buy |
| 2024-03-12 | Oppenheimer | Reiterate | Outperform -> Outperform |
| 2024-03-12 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-01-30 | Citigroup | Initiate | Buy |
| 2023-10-11 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-09-15 | JP Morgan | Maintains | Overweight -> Overweight |
| 2023-09-06 | Oppenheimer | Reiterate | Outperform -> Outperform |
| 2023-09-05 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-08-10 | JP Morgan | Maintains | Overweight -> Overweight |
| 2023-08-09 | Credit Suisse | Maintains | Outperform -> Outperform |
| 2023-08-09 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-07-21 | Oppenheimer | Initiate | Outperform |
| 2023-05-11 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-03-10 | Credit Suisse | Maintains | Outperform |
| 2023-03-10 | HC Wainwright & Co. | Maintains | Buy |
| 2023-02-22 | Credit Suisse | Initiate | Outperform |
| 2022-06-10 | HC Wainwright & Co. | Upgrade | Neutral -> Buy |
| 2022-02-28 | HC Wainwright & Co. | Initiate | Neutral |